Ashland sees Q3 sales down ~15%, EBITDA down 22-25%; cuts FY23 outlook; announces $1B buyback

ASHLAND INC.

Preliminary Q3 sales expected $545-550M (down ~15% YoY); adjusted EBITDA $130-135M (down 22-25%).
Updated FY2023 outlook: if de-stocking persists, sales ~$2.2B and adjusted EBITDA ~$500M.
Board approved new $1B evergreen share repurchase authorization; replaces $500M auth with $200M remaining.
Since Sep 30, 2022, repurchased ~$300M; additional targeted restructuring actions planned.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.